J9262 Injection, omacetaxine mep, 0.01mg
Also known as: omacetaxine, Synribo
Injection of omacetaxine mepesuccinate, 0.01 milligram. A topoisomerase I inhibitor used primarily for chronic myeloid leukemia treatment.
In Plain Language
leukemia cancer injection; blood cancer treatment
Clinical Context
Used for patients with chronic myeloid leukemia who are resistant to tyrosine kinase inhibitors. Often used for Philadelphia chromosome-positive disease refractory to standard therapy.
RVU Information
CPT J9262 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9262?
CPT J9262 (Injection, omacetaxine mep, 0.01mg) is a J Codes (Drugs) code. Injection of omacetaxine mepesuccinate, 0.01 milligram. A topoisomerase I inhibitor used primarily for chronic myeloid leukemia treatment.
How is J9262 administered?
CPT J9262 is administered by a healthcare provider, typically via injection or infusion. Used for patients with chronic myeloid leukemia who are resistant to tyrosine kinase inhibitors. Often used for Philadelphia chromosome-positive disease refractory to standard therapy. It is used by Oncology, Hematology, Internal Medicine.
When is CPT J9262 used?
Used for patients with chronic myeloid leukemia who are resistant to tyrosine kinase inhibitors. Often used for Philadelphia chromosome-positive disease refractory to standard therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.